NASDAQ:HZNP • IE00BQPVQZ61
Past quarterly earnings results for HORIZON THERAPEUTICS PLC (HZNP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | 1.20 | 1.05 | 13.95% | 12.15% | 944.959M | 885.04M | 6.77% | 7.82% |
| Q1 2023 | 0.83 | 1.14 | -27.35% | -38.06% | 832.059M | 920.33M | -9.59% | -6.01% |
| Q4 2022 | 1.21 | 1.11 | 8.82% | -14.18% | 942.029M | 941.38M | 0.07% | -7.14% |
| Q3 2022 | 1.25 | 1.03 | 21.50% | -28.57% | 925.359M | 905.78M | 2.16% | -10.77% |
| Q2 2022 | 1.07 | 1.37 | -21.80% | -33.95% | 876.411M | 957.55M | -8.47% | 5.27% |
| Q1 2022 | 1.34 | 1.16 | 15.18% | 4,366.67% | 885.245M | 883.71M | 0.17% | 158.54% |
| Q4 2021 | 1.41 | 1.37 | 2.75% | 10.16% | 1.014B | 1.016B | -0.15% | 36.11% |
| Q3 2021 | 1.75 | 1.57 | 11.65% | 0.57% | 1.037B | 997.3M | 3.98% | 62.95% |
| Q2 2021 | 1.62 | 0.90 | 80.18% | 305.00% | 832.548M | 711.66M | 16.99% | 79.89% |
| Q1 2021 | 0.03 | 0.05 | -38.26% | -92.50% | 342.4M | 332.81M | 2.88% | -3.79% |
| Q4 2020 | 1.28 | 1.08 | 18.26% | - | 745.3M | 707.41M | 5.36% | - |
| Q3 2020 | 1.74 | 0.99 | 76.31% | - | 636.4M | 535.58M | 18.82% | - |
| Q2 2020 | 0.40 | 0.36 | 9.95% | - | 462.8M | 339.1M | 36.48% | - |
| Q1 2020 | 0.40 | 0.22 | 84.98% | - | 355.9M | 293.64M | 21.20% | - |
Notes
HORIZON THERAPEUTICS PLC (HZNP) last reported earnings on 8/8/2023.
HORIZON THERAPEUTICS PLC (HZNP) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, HORIZON THERAPEUTICS PLC (HZNP) has beaten EPS estimates in 3 out of 4 releases.